[CH3:1][NH:2][S:3]([CH2:6][C:7]1[CH:8]=[CH:9][C:10]2[NH:15][CH:14]=[C:13]([CH2:16][CH2:17][N:18]([CH3:20])[CH3:19])[C:11]=2[CH:12]=1)(=[O:5])=[O:4].[OH:21][C:22]([CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH3:32])=[O:23]>C(OCC)(=O)C>[CH3:1][NH:2][S:3]([CH2:6][C:7]1[CH:8]=[CH:9][C:10]2[NH:15][CH:14]=[C:13]([CH2:16][CH2:17][N:18]([CH3:20])[CH3:19])[C:11]=2[CH:12]=1)(=[O:5])=[O:4].[O-:23][C:22]([CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH3:32])=[O:21]Sumatriptan base ((2.29g; 7.75 mmol) was dissolved in boiling ethyl acetate (300 mL) with stirring. Capric acid (1.33 g; 7.75 mmol) was dissolved in ethyl acetate (10 mL) and added to the sumatriptan base solution in one portion. The hot solution was stirred for a further 10 minutes and allowed to cool to room temperature. Evaporation of the solvent by rotary evaporation rave a pale yellow oil. Hexane (50 mL) was added and a white precipitate formed that was filtered off under vacuum. The precipitate was washed with hexane and allowed to dry at room temperature to give sumatriptan caprate as a pale yellow solid (2.79 g; 77.4%). The sumatriptan caprate was characterised by DSC and FT-IR. DSC gave a single, sharp endotherm with the onset at 94.6° C. The FT-IR differed significantly from that of the sumatriptan base.